Role of autophagy in alcohol and drug-induced liver injury

被引:45
|
作者
Williams, Jessica A. [1 ]
Ding, Wen-Xing [1 ]
机构
[1] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, MS 1018,3901 Rainbow Blvd, Kansas City, KS 66160 USA
关键词
Alcohol; Autophagy; Lipophagy; Liver; Mitophagy; DILI; INDUCED MITOCHONDRIAL DYSFUNCTION; INITIATING KINASE ULK1; SMALL GTPASE RAB7; PROTEIN ADDUCTS; PATHOPHYSIOLOGICAL ROLES; CELL-DEATH; IN-VIVO; ACETAMINOPHEN; PINK1; MECHANISM;
D O I
10.1016/j.fct.2019.111075
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Alcohol-related liver disease (ALD) and drug-induced liver injury (DILI) are common causes of severe liver disease, and successful treatments are lacking. Autophagy plays a protective role in both ALD and DILI by selectively removing damaged mitochondria (mitophagy), lipid droplets (lipophagy), protein aggregates and adducts in hepatocytes. Autophagy also protects against ALD by degrading interferon regulatory factor 1 (IRF1) and damaged mitochondria in hepatic macrophages. Specifically, we will discuss selective autophagy for removal of damaged mitochondria and lipid droplets in hepatocytes and autophagy-mediated degradation of IRF1 in hepatic macrophages as protective mechanisms against alcohol-induced liver injury and steatosis. In addition, selective autophagy for removal of damaged mitochondria and protein adducts for protection against DILI is discussed in this review. Development of new therapeutics for ALD and DILI is greatly needed, and selective autophagy pathways may provide promising targets. Drug and alcohol effects on autophagy regulation as well as protective mechanisms of autophagy against DILI and ALD are highlighted in this review.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Drug-induced liver injury
    Kumachev, Alexander
    Wu, Peter E.
    [J]. CANADIAN MEDICAL ASSOCIATION JOURNAL, 2021, 193 (20) : E746 - E747
  • [22] Drug-Induced Liver Injury
    Fisher, Kurt
    Vuppalanchi, Raj
    Saxena, Romil
    [J]. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2015, 139 (07) : 876 - 887
  • [23] Drug-induced liver injury
    Kaplowitz, N
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 38 : S44 - S48
  • [24] Drug-induced liver injury
    Raul J. Andrade
    Naga Chalasani
    Einar S. Björnsson
    Ayako Suzuki
    Gerd A. Kullak-Ublick
    Paul B. Watkins
    Harshad Devarbhavi
    Michael Merz
    M. Isabel Lucena
    Neil Kaplowitz
    Guruprasad P. Aithal
    [J]. Nature Reviews Disease Primers, 5
  • [26] Drug-induced liver injury
    Abboud, Gebran
    Kaplowitz, Neil
    [J]. DRUG SAFETY, 2007, 30 (04) : 277 - 294
  • [27] Drug-induced liver injury
    Bjornsson, Einar S.
    [J]. LAEKNABLADID, 2010, 96 (03): : 175 - 182
  • [28] Drug-Induced Liver Injury
    Gebran Abboud
    Neil Kaplowitz
    [J]. Drug Safety, 2007, 30 : 277 - 294
  • [29] Drug-Induced Liver Injury in Pregnancy The US Drug-Induced Liver Injury Network Experience
    Masood, Umair
    Venturini, Nicholas
    Nicoletti, Paola
    Dellinger, Andrew
    Kleiner, David
    Bonkovsky, Herbert L.
    Barnhart, Huiman
    Vuppalanchi, Raj
    Rossi, Simona
    Odin, Joseph A.
    Kushner, Tatyana
    [J]. OBSTETRICS AND GYNECOLOGY, 2024, 143 (06): : 819 - 823
  • [30] Role of the innate immune system in drug-induced liver injury
    Ju, Cynthia
    You, Qiang
    Holt, Michael
    Cheng, Linling
    Pohl, Lance R.
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 234